19-42729874-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021016.4(PSG3):c.892C>T(p.Pro298Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000098 in 1,612,596 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021016.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSG3 | NM_021016.4 | c.892C>T | p.Pro298Ser | missense_variant | 4/7 | ENST00000327495.10 | NP_066296.2 | |
PSG3 | XM_011527126.3 | c.776-497C>T | intron_variant | XP_011525428.1 | ||||
PSG3 | XM_011527127.3 | c.775+2910C>T | intron_variant | XP_011525429.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSG3 | ENST00000327495.10 | c.892C>T | p.Pro298Ser | missense_variant | 4/7 | 1 | NM_021016.4 | ENSP00000332215.5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000159 AC: 40AN: 250940Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135644
GnomAD4 exome AF: 0.0000965 AC: 141AN: 1460420Hom.: 0 Cov.: 38 AF XY: 0.0000867 AC XY: 63AN XY: 726524
GnomAD4 genome AF: 0.000112 AC: 17AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.892C>T (p.P298S) alteration is located in exon 4 (coding exon 4) of the PSG3 gene. This alteration results from a C to T substitution at nucleotide position 892, causing the proline (P) at amino acid position 298 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at